|
1
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S,
Lobie PE and Zhu T: c-MYC-regulated miR-23a/24-2/27a cluster
promotes mammary carcinoma cell invasion and hepatic metastasis by
targeting Sprouty2. J Biol Chem. 288:18121–18133. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Christopher AF, Kaur RP, Kaur G, Kaur A,
Gupta V and Bansal P: MicroRNA therapeutics: Discovering novel
targets and developing specific therapy. Perspect Clin Res.
7:68–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feng Q, Wu Q, Liu X, Xiong Y and Li H:
MicroRNA-137 acts as a tumor suppressor in osteosarcoma by
targeting enhancer of zeste homolog 2. Exp Ther Med. 13:3167–3174.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Chen W, Zeng W, Wan C, Duan S and
Jiang S: microRNA-137 promotes apoptosis in ovarian cancer cells
via the regulation of XIAP. Br J Cancer. 116:66–76. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun L, Liang J, Wang Q, Li Z, Du Y and Xu
X: MicroRNA-137 suppresses tongue squamous carcinoma cell
proliferation, migration and invasion. Cell Prolif. 49:628–635.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu L, Chen J, Ding C, Wei S, Zhu Y, Yang
W, Zhang X, Wei X and Han D: MicroRNA-137 contributes to dampened
tumorigenesis in human gastric cancer by targeting AKT2. PLoS One.
10:e01301242015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deng Y, Deng H, Bi F, Liu J, Bemis LT,
Norris D, Wang XJ and Zhang Q: MicroRNA-137 targets
carboxyl-terminal binding protein 1 in melanoma cell lines. Int J
Biol Sci. 7:133–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luo C, Tetteh PW, Merz PR, Dickes E,
Abukiwan A, Hotz-Wagenblatt A, Holland-Cunz S, Sinnberg T, Schittek
B, Schadendorf D, et al: miR-137 inhibits the invasion of melanoma
cells through downregulation of multiple oncogenic target genes. J
Invest Dermatol. 133:768–775. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo J, Xia B, Meng F and Lou G: miR-137
suppresses cell growth in ovarian cancer by targeting AEG-1.
Biochem Biophys Res Commun. 441:357–363. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jansen R, Embden JD, Gaastra W and Schouls
LM: Identification of genes that are associated with DNA repeats in
prokaryotes. Mol Microbiol. 43:1565–1575. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barrangou R, Fremaux C, Deveau H, Richards
M, Boyaval P, Moineau S, Romero DA and Horvath P: CRISPR provides
acquired resistance against viruses in prokaryotes. Science.
315:1709–1712. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ishino Y, Shinagawa H, Makino K, Amemura M
and Nakata A: Nucleotide sequence of the iap gene, responsible for
alkaline phosphatase isozyme conversion in Escherichia coli, and
identification of the gene product. J Bacteriol. 169:5429–5433.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mali P, Yang L, Esvelt KM, Aach J, Guell
M, DiCarlo JE, Norville JE and Church GM: RNA-guided human genome
engineering via Cas9. Science. 339:823–826. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cong L, Ran FA, Cox D, Lin S, Barretto R,
Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA and Zhang F:
Multiplex genome engineer using CRISPR/Cas systems. Science.
339:819–823. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
LaFountaine JS, Fathe K and Smyth HD:
Delivery and therapeutic applications of gene editing technologies
ZFNs, TALENs, and CRISPR/Cas9. Int J Pharm. 494:180–194. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sakuma T, Nishikawa A, Kume S, Chayama K
and Yamamoto T: Multiplex genome engineering in human cells using
all-in-one CRISPR/Cas9 vector system. Sci Rep. 4:54002014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schwank G, Koo BK, Sasselli V, Dekkers JF,
Heo I, Demircan T, Sasaki N, Boymans S, Cuppen E, van der Ent CK,
et al: Functional repair of CFTR by CRISPR/Cas9 in intestinal stem
cell organoids of cystic fibrosis patients. Cell Stem Cell.
13:653–658. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Y, Liang D, Wang Y, Bai M, Tang W, Bao
S, Yan Z, Li D and Li J: Correction of a genetic disease in mouse
via use of CRISPR-Cas9. Cell Stem Cell. 13:659–662. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hruscha A, Krawitz P, Rechenberg A,
Heinrich V, Hecht J, Haass C and Schmid B: Efficient CRISPR/Cas9
genome editing with low off-target effects in zebrafish.
Development. 140:4982–4987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Friedland AE, Tzur YB, Esvelt KM,
Colaiacovo MP, Church GM and Calarco JA: Heritable genome editing
in C. Elegans via a CRISPR-Cas9 system. Nat Methods. 10:741–743.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu Z, Ren M, Wang Z, Zhang B, Rong YS,
Jiao R and Gao G: Highly efficient genome modifications mediated by
CRISPR/Cas9 in Drosophila. Genetics. 195:289–291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao Y, Dai Z, Liang Y, Yin M, Ma K, He M,
Ouyang H and Teng CB: Sequence-specific inhibition of microRNA via
CRISPR/CRISPRi system. Sci Rep. 4:39432014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hsu PD, Lander ES and Zhang F: Development
and applications of CRISPR-Cas9 for genome engineering. Cell.
157:1262–1278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Doudna JA and Charpentier E: Genome
editing. The new frontier of genome engineering with CRISPR-Cas9.
Science. 346:92014. View Article : Google Scholar
|
